Through the Genentech Innovation Fund, we invest in bold ideas that break down barriers to equitable care and patient outcomes. Since launching the Innovation Fund in 2019, Genentech has invested $50M in groundbreaking innovation, catalyzing over 100+ healthcare organizations and leaders unified by a vision to address today’s most urgent health challenges.
Click the tiles below to learn more about the impact of our Innovation Fund partners
A majority of our Innovation Fund Grantees said that, as a result of Genentech’s support, they’re able to execute transformative work that drives progress toward health equity and elevates them within their fields of study. In addition:
TOUCH, The Black Breast Cancer Alliance launched the groundbreaking When We Tri(al) initiative, which is activating a joyful, energized community to overcome Black women’s justifiable mistrust of clinical research.
Changemaker Reflections: Hear More From Touch Co-founder & CEO Ricki FairleyEquify Health is disrupting how medical providers deliver care using transformative approaches centered on the humanity of patients as people, as opposed to their diagnoses.
Changemaker Reflections: Hear More From Equify Founder & CEO Sylvie LeotinHenry Ford Health (HFH) launched the Participatory Action for Access to Clinical Trials (PAACT) project to increase Black/African American clinical trial participation by partnering with community groups.
Changemaker Reflections: Hear More From Paact Principal Investigator Dr. Evelyn JiaggeSee recent news coverage of our Innovation Fund grantees and explore other stories about Genentech’s work to improve health equity.